Finance

Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

Business Insider By Hilary Brueck Oct 28, 2026 · 5:45 AM 3 min read 0 views 0 comments

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led to more weight loss.

Business Insider Original story · www.businessinsider.com

How does this story make you feel?

Discussion (0)

No comments yet. Start the conversation!